CN107699589B - 一种Cre和Flp依赖的逆向示踪重组伪狂犬病毒的制备方法和应用 - Google Patents
一种Cre和Flp依赖的逆向示踪重组伪狂犬病毒的制备方法和应用 Download PDFInfo
- Publication number
- CN107699589B CN107699589B CN201710365548.XA CN201710365548A CN107699589B CN 107699589 B CN107699589 B CN 107699589B CN 201710365548 A CN201710365548 A CN 201710365548A CN 107699589 B CN107699589 B CN 107699589B
- Authority
- CN
- China
- Prior art keywords
- pseudorabies virus
- cre
- flp
- fluorescent protein
- virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000701093 Suid alphaherpesvirus 1 Species 0.000 title claims abstract description 145
- 230000001419 dependent effect Effects 0.000 title claims abstract description 44
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 241000700605 Viruses Species 0.000 claims abstract description 60
- 229960005486 vaccine Drugs 0.000 claims abstract description 9
- 238000004458 analytical method Methods 0.000 claims abstract description 8
- 229940079593 drug Drugs 0.000 claims abstract description 6
- 239000003814 drug Substances 0.000 claims abstract description 6
- 238000010171 animal model Methods 0.000 claims abstract description 5
- 108010043121 Green Fluorescent Proteins Proteins 0.000 claims description 55
- 108010054624 red fluorescent protein Proteins 0.000 claims description 51
- 102000004144 Green Fluorescent Proteins Human genes 0.000 claims description 47
- 239000005090 green fluorescent protein Substances 0.000 claims description 47
- 239000013612 plasmid Substances 0.000 claims description 18
- 238000010276 construction Methods 0.000 claims description 11
- 210000003792 cranial nerve Anatomy 0.000 claims description 10
- 230000006798 recombination Effects 0.000 claims description 9
- 238000005215 recombination Methods 0.000 claims description 9
- 238000001976 enzyme digestion Methods 0.000 claims description 7
- 238000012408 PCR amplification Methods 0.000 claims description 6
- 241000124008 Mammalia Species 0.000 claims description 3
- 239000012228 culture supernatant Substances 0.000 claims description 3
- 238000011161 development Methods 0.000 claims description 3
- 238000004113 cell culture Methods 0.000 claims description 2
- 230000008506 pathogenesis Effects 0.000 claims description 2
- 230000010076 replication Effects 0.000 claims description 2
- 230000009385 viral infection Effects 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000010534 mechanism of action Effects 0.000 claims 1
- 230000001537 neural effect Effects 0.000 abstract description 10
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 5
- 108091006047 fluorescent proteins Proteins 0.000 abstract description 5
- 230000003950 pathogenic mechanism Effects 0.000 abstract description 5
- 238000007877 drug screening Methods 0.000 abstract description 4
- 102000034287 fluorescent proteins Human genes 0.000 abstract description 4
- 230000007246 mechanism Effects 0.000 abstract description 4
- 230000029812 viral genome replication Effects 0.000 abstract description 4
- 238000012827 research and development Methods 0.000 abstract description 2
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 abstract 2
- 102000057593 human F8 Human genes 0.000 abstract 2
- 229940047431 recombinate Drugs 0.000 abstract 2
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 85
- 101150042777 flp gene Proteins 0.000 description 80
- 108020004414 DNA Proteins 0.000 description 44
- 230000015572 biosynthetic process Effects 0.000 description 37
- 238000003786 synthesis reaction Methods 0.000 description 37
- 210000004556 brain Anatomy 0.000 description 32
- 208000015181 infectious disease Diseases 0.000 description 18
- 238000000034 method Methods 0.000 description 18
- 238000003752 polymerase chain reaction Methods 0.000 description 17
- 108091005948 blue fluorescent proteins Proteins 0.000 description 16
- 238000011160 research Methods 0.000 description 13
- 210000005013 brain tissue Anatomy 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 241000700159 Rattus Species 0.000 description 11
- 241001465754 Metazoa Species 0.000 description 10
- 239000012634 fragment Substances 0.000 description 9
- 241000699666 Mus <mouse, genus> Species 0.000 description 8
- 229930040373 Paraformaldehyde Natural products 0.000 description 8
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 8
- 229930006000 Sucrose Natural products 0.000 description 8
- 229920002866 paraformaldehyde Polymers 0.000 description 8
- 239000005720 sucrose Substances 0.000 description 8
- 230000003612 virological effect Effects 0.000 description 8
- 241000282414 Homo sapiens Species 0.000 description 7
- 101150063416 add gene Proteins 0.000 description 7
- 238000012258 culturing Methods 0.000 description 7
- 210000002569 neuron Anatomy 0.000 description 7
- 238000012163 sequencing technique Methods 0.000 description 7
- 238000012795 verification Methods 0.000 description 7
- 238000005119 centrifugation Methods 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 230000006801 homologous recombination Effects 0.000 description 6
- 238000002744 homologous recombination Methods 0.000 description 6
- 238000013528 artificial neural network Methods 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- 241001529936 Murinae Species 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000008014 freezing Effects 0.000 description 4
- 238000007710 freezing Methods 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000004806 packaging method and process Methods 0.000 description 4
- 238000002791 soaking Methods 0.000 description 4
- 108010030074 endodeoxyribonuclease MluI Proteins 0.000 description 3
- 108010048367 enhanced green fluorescent protein Proteins 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000000703 high-speed centrifugation Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 230000001766 physiological effect Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 208000012902 Nervous system disease Diseases 0.000 description 2
- 208000025966 Neurological disease Diseases 0.000 description 2
- 101150003725 TK gene Proteins 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 230000003925 brain function Effects 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 239000000700 radioactive tracer Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000012800 visualization Methods 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 241000700586 Herpesviridae Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000595467 Homo sapiens T-complex protein 1 subunit gamma Proteins 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 102100036049 T-complex protein 1 subunit gamma Human genes 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000012761 co-transfection Methods 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 230000001149 cognitive effect Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000001638 lipofection Methods 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000009447 viral pathogenesis Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/65—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16721—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16731—Uses of virus other than therapeutic or vaccine, e.g. disinfectant
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16751—Methods of production or purification of viral material
- C12N2710/16752—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Toxicology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710365548.XA CN107699589B (zh) | 2017-05-22 | 2017-05-22 | 一种Cre和Flp依赖的逆向示踪重组伪狂犬病毒的制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710365548.XA CN107699589B (zh) | 2017-05-22 | 2017-05-22 | 一种Cre和Flp依赖的逆向示踪重组伪狂犬病毒的制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107699589A CN107699589A (zh) | 2018-02-16 |
CN107699589B true CN107699589B (zh) | 2019-12-13 |
Family
ID=61169526
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710365548.XA Active CN107699589B (zh) | 2017-05-22 | 2017-05-22 | 一种Cre和Flp依赖的逆向示踪重组伪狂犬病毒的制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107699589B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109266682B (zh) * | 2018-09-29 | 2022-04-01 | 中国科学院武汉物理与数学研究所 | 一种神经细胞快速逆行跨突触标记的方法及应用 |
CN109628415A (zh) * | 2018-12-13 | 2019-04-16 | 中国科学院深圳先进技术研究院 | 三级神经环路操纵组合物及动物三级神经环路操纵方法 |
CN109943539A (zh) * | 2019-03-28 | 2019-06-28 | 中国科学院武汉物理与数学研究所 | 一种高亮表达红色荧光蛋白的逆向神经环路示踪的重组伪狂犬病毒的制备方法和应用 |
CN109880807B (zh) * | 2019-03-29 | 2022-07-29 | 中国科学院武汉物理与数学研究所 | 神经细胞稀疏高亮度标记重组腺相关病毒的包装方法及其应用 |
CN110331166B (zh) * | 2019-07-31 | 2023-02-03 | 中国科学院武汉物理与数学研究所 | Cre和flp双重组酶级联控制的逆行跨单突触的辅助载体及其应用 |
WO2021114255A1 (zh) * | 2019-12-13 | 2021-06-17 | 中国科学院深圳先进技术研究院 | 一种用于研究脑-肠神经环路的方法及其应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103981153A (zh) * | 2014-05-29 | 2014-08-13 | 中国兽医药品监察所 | 伪狂犬病病毒双荧光标记缺失病毒的构建 |
CN106520709A (zh) * | 2016-11-07 | 2017-03-22 | 中国科学院武汉病毒研究所 | 顺行跨单级突触神经示踪系统 |
WO2017048808A1 (en) * | 2015-09-15 | 2017-03-23 | The Board Of Trustees Of The Leland Stanford Junior University | Light-responsive polypeptides and methods of use thereof |
-
2017
- 2017-05-22 CN CN201710365548.XA patent/CN107699589B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103981153A (zh) * | 2014-05-29 | 2014-08-13 | 中国兽医药品监察所 | 伪狂犬病病毒双荧光标记缺失病毒的构建 |
WO2017048808A1 (en) * | 2015-09-15 | 2017-03-23 | The Board Of Trustees Of The Leland Stanford Junior University | Light-responsive polypeptides and methods of use thereof |
CN106520709A (zh) * | 2016-11-07 | 2017-03-22 | 中国科学院武汉病毒研究所 | 顺行跨单级突触神经示踪系统 |
Non-Patent Citations (6)
Title |
---|
A Dual Infection Pseudorabies Virus Conditional Reporter Approach to Identify Projections to Collateralized Neurons in Complex Neural Circuits;J. Patrick Card et al.;《PLoS One》;20110616;第6卷(第6期);第1-12页 * |
Cloning vector Ble-mCherry, partial sequence;Wang,Q.et al.;《GenBank: KX446949.1》;20160814;FEATURES和ORIGIN部分 * |
FlEx-based transgenic reporter lines for visualization of Cre and Flp activity in live zebrafish;Boniface EJ,et al.;《Genesis.》;20090731;第47卷(第7期);第1页第1段至第5页最后1段,图1-4 * |
Suid herpesvirus 1 strain Bartha, complete genome;Szpara,M.L.et al.;《GenBank: JF797217.1》;20111102;FEATURES和ORIGIN部分 * |
Virus-Assisted Mapping of Neural Inputs to a Feeding Center in the Hypothalamus;Jeff DeFalco,et al.;《Science 》;20010330;第291卷(第5513期);摘要,第1页第1段至第5页最后1段,图1-4 * |
利用嗜神经病毒跨突触追踪神经网络研究进展;张志建等;《生命科学》;20140630;第26卷(第6期);第634-643页 * |
Also Published As
Publication number | Publication date |
---|---|
CN107699589A (zh) | 2018-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107699589B (zh) | 一种Cre和Flp依赖的逆向示踪重组伪狂犬病毒的制备方法和应用 | |
KR102272932B1 (ko) | 이종 유전자로 무장된 종양살상 아데노바이러스 | |
CN111712257B (zh) | 携带双特异性T细胞衔接器(BiTE)的腺病毒 | |
CN107723276B (zh) | 一种稳定高表达目标产物的细胞株的构建方法和试剂盒 | |
KR20190043164A (ko) | 이중특이성 T 세포 세포 관여자(BiTE)가 보강된 아데노바이러스 | |
KR20200004408A (ko) | 뉴캐슬병 바이러스 및 이의 용도 | |
KR20140107295A (ko) | 진핵 세포용 전장 항체 표시 시스템 및 그것의 용도 | |
KR102365484B1 (ko) | 하이브리드 chef1 프로모터를 이용한 향상된 재조합 단백질 발현 | |
KR20210013589A (ko) | 면역 체크포인트 억제제 공동-발현 벡터 | |
CN114805500B (zh) | 非洲猪瘟病毒i73r蛋白作为免疫抑制剂的应用及免疫抑制位点突变毒株的构建 | |
CN106536722B (zh) | 用于快速制备感染性rna病毒的方法 | |
CN113039272B (zh) | 转录调节元件及其在增强异源蛋白表达中的应用 | |
TW200813223A (en) | High-yield transgenic mammalian expression system for generating virus-like particles | |
CN102329784A (zh) | 一种日本乙型脑炎病毒样颗粒及其制备方法和应用 | |
JP2021502822A (ja) | in vitro及びin vivoでの遺伝子送達のための非ヒトパピローマウイルス | |
CN109970861B (zh) | 一种靶向线粒体的nd4融合蛋白及其制备方法和应用 | |
CN114196639B (zh) | 表达3型鸭甲型肝炎病毒p1和3c基因的重组鸭瘟病毒及其构建方法和用途 | |
RU2731293C1 (ru) | Способ получения генно-модифицированных линий клеток натуральных киллеров с нокаутированным геном PD-1 и повышенной экспрессией белков семейства Фактора Некроза Опухолей для иммунотерапии онкологических заболеваний | |
GB2540786A (en) | Codon optimised tet repressor proteins | |
CN115176016A (zh) | 增强的表达系统及其使用方法 | |
CN108727491B (zh) | 一种单克隆抗体zk7c3及应用 | |
CN111574621A (zh) | 一种中和eb病毒的单克隆抗体及其应用 | |
CN115287271A (zh) | 一种检测SARS-CoV-2抗体中和活性的方法 | |
CN115029380B (zh) | 一种新型冠状病毒SARS-CoV-2复制子及其细胞模型、构建方法和应用 | |
KR20120079389A (ko) | 3D8 scFv 유전자가 도입된 형질전환 닭 및 그 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20211217 Address after: 430056 unit 2, 3 / F, F10 R & D building, phase I, Huazhong Huihe science and Technology Park (Huazhong Zhigu), plot 201m, Wuhan Economic and Technological Development Zone, Hubei Province (zkcx-317) Patentee after: Aoao Biotechnology (Wuhan) Co.,Ltd. Address before: 518107 floor 17, building 4, Weiguang Life Science Park, Zhenmei community, Xinhu street, Guangming District, Shenzhen, Guangdong Patentee before: Brincase (Shenzhen) Biotechnology Co.,Ltd. Effective date of registration: 20211217 Address after: 518107 floor 17, building 4, Weiguang Life Science Park, Zhenmei community, Xinhu street, Guangming District, Shenzhen, Guangdong Patentee after: Brincase (Shenzhen) Biotechnology Co.,Ltd. Address before: 430071 Xiao Hong, Wuchang District, Wuhan District, Hubei, Shanxi, 30 Patentee before: Institute of precision measurement science and technology innovation, Chinese Academy of Sciences Effective date of registration: 20211217 Address after: 430071 Xiao Hong, Wuchang District, Wuhan District, Hubei, Shanxi, 30 Patentee after: Institute of precision measurement science and technology innovation, Chinese Academy of Sciences Address before: 430071 Xiao Hong, Wuchang District, Wuhan District, Hubei, Shanxi, 30 Patentee before: WUHAN INSTITUTE OF PHYSICS AND MATHEMATICS, CHINESE ACADEMY OF SCIENCES |
|
TR01 | Transfer of patent right |